ASH2L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.652800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.540200E-01
Normal-vs-Stage2
4.671200E-01
Normal-vs-Stage3
3.868200E-02
Normal-vs-Stage4
7.612800E-01
Stage1-vs-Stage2
6.369400E-01
Stage1-vs-Stage3
7.217200E-01
Stage1-vs-Stage4
2.259000E-01
Stage2-vs-Stage3
4.359400E-01
Stage2-vs-Stage4
2.489800E-01
Stage3-vs-Stage4
5.730000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.750400E-01
Normal-vs-AfricanAmerican
3.817400E-01
Normal-vs-Asian
1.712760E-01
Caucasian-vs-AfricanAmerican
9.971400E-01
Caucasian-vs-Asian
5.625000E-01
AfricanAmerican-vs-Asian
6.116600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.662200E-01
Normal-vs-Female
2.989200E-01
Male-vs-Female
5.850200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.969800E-02
Normal-vs-Age(41-60Yrs)
4.765200E-01
Normal-vs-Age(61-80Yrs)
3.815400E-01
Normal-vs-Age(81-100Yrs)
9.935000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.227700E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.259400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.942800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.530400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.641800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.763000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.006040E-01
Normal-vs-Daily Drinker
5.674800E-01
Normal-vs-Weekly Drinker
2.049800E-01
Normal-vs-Occasional Drinker
7.546800E-01
Normal-vs-Social Drinker
5.903200E-01
Non Drinker-vs-Daily Drinker
5.957400E-01
Non Drinker-vs-Weekly Drinker
5.405600E-01
Non Drinker-vs-Occasional Drinker
2.296300E-02
Non Drinker-vs-Social Drinker
1.536760E-01
Daily Drinker-vs-Weekly Drinker
9.023800E-01
Daily Drinker-vs-Occasional Drinker
3.591200E-01
Daily Drinker-vs-Social Drinker
6.744600E-01
Weekly Drinker-vs-Occasional Drinker
1.681440E-01
Weekly Drinker-vs-Social Drinker
4.727000E-01
Occasional Drinker-vs-Social Drinker
6.130600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.806200E-01
Normal-vs-Grade 2
4.234300E-02
Normal-vs-Grade 3
9.576100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.575400E-01
Grade 1-vs-Grade 3
4.545500E-02
Grade 1-vs-Grade 4
2.806200E-01
Grade 2-vs-Grade 3
7.166400E-02
Grade 2-vs-Grade 4
4.234300E-02
Grade 3-vs-Grade 4
9.576100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.882200E-01
Normal-vs-NonDiabetic
4.673600E-01
Diabetic-vs-NonDiabetic
3.203800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.838100E-02
Normal-vs-NoPancreatitis
4.748800E-01
Pancreatitis-vs-NoPancreatitis
2.326200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.129400E-01
Normal-vs-N1
4.569600E-01
N0-vs-N1
9.853600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.923800E-01
Normal-vs-TP53-NonMutant
4.569200E-01
TP53-Mutant-vs-TP53-NonMutant
7.499700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
